Our Products
Tadalista 20 Mg contains an active ingredient, Tadalafil, which is used to treat Erectile Dysfunction in men. Tadalista 20 Mg is a prescription based drug which may be available at any of the drugstores, leading online pharmacy stores, and medical supply stores.
What Are The Uses Of The Tadalista 20 Mg (Tadalafil):
Tadalista 20 Mg is used to treat:
How Tadalista 20 Mg (Tadalafil) Works:
Tadalafil (PDE-5 inhibitor) is an active salt in Tadalista 20 Mg tablet which is increases the blood flow to the relaxing the muscles in penile blood vessels hence, treating Erectile Dysfunctioning. It also treats pulmonary hypertension by relaxing the blood vessels in the lungs to allow blood to flow more easily.
Before You Use Tadalista 20 Mg (Tadalafil):
Make sure that:
Myelostat 500mg Capsule is used in the treatment of some kinds of cancer and to prevent painful episodes associated with sickle cell anemia. It may be also used to treat some other conditions. It is sometimes used with certain other medicines as part of combination chemotherapy.
Take this medicine in the dose and duration as advised by your doctor. Myelostat 500mg Capsule may be taken with or without food, but it is better to take it at a fixed time.
Benoquin Cream is used for depigmentation. It is used to permanently lighten the skin in people with extensive vitiligo. It works by increasing the elimination of melanin from skin cells.
Benoquin Cream is for external use only. You should always use it exactly as your doctor has told you. You must wash your hands thoroughly before and after applying this medicine. This medicine should be used regularly to get the most benefit from it. Do not use more than you need as some side effects may be increased.
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and apply the cream. Wash your hands after applying, unless hands are the affected area.
Celrixafor is the Generic version of Mozobil (PLERIXAFOR)
On December 15, 2008, the U. S. Food and Drug Administration (FDA) approved plerixafor, solution forsubcutaneousinjection, (Mozobil, Genzyme Corp.) for use in combination with granulocyte-colony stimulating factor (G-CSF) to mobilizehematopoieticstem cellsto theperipheral bloodfor collection and subsequentautologoustransplantation in patients with non-Hodgkin lymphoma (NHL) and multiple myeloma (MM).
Peripheral blood stem cell mobilization, which is important as a source ofhematopoietic stem cellsfortransplantation, is usually performed usinggranulocyte colony-stimulating factor(G-CSF), but is ineffective in around 15 to 20% of patients. Combination of G-CSF with Celrixafor (Plerixafor) increases the percentage of persons that respond to the therapy and produce enough stem cells for transplantation